Smart Blood Analytics Swiss SA

Smart Blood Analytics Swiss SA develops diagnostic software called SBAS, which analyzes blood sample data to generate a list of probable diseases. The software helps distinguish between viral and bacterial infections by processing laboratory results with advanced algorithms. These devices are designed to assist healthcare professionals in identifying potential conditions based on biological data.

The company is headquartered in Switzerland. This location reflects its focus on developing innovative diagnostic tools, likely leveraging Switzerland’s strong reputation for precision engineering and medical technology.

The company’s devices are listed in the eudamed database, which is the official EU registry for medical devices. This inclusion ensures transparency and compliance with EU regulatory requirements for Class IIa devices.

The company’s products fall under EU Class IIa medical devices. This classification is determined by the risk associated with the device—Class IIa devices pose a moderate risk and require compliance with specific EU Medical Device Regulations (MDR) or In Vitro Diagnostic Regulation (IVDR) requirements to ensure safety and performance.